Telbivudine globe trial at year two: Efficacy, safety, and predictors of outcome in patients with chronic hepatitis B

被引：0
|
作者：
Han, Steven-Huy
Lai, Ching Lung
Gane, Edward J.
Liaw, Yun-Fan
Thongsawar, Satawat
Wang, Yuming
Chen, Yagang
Heathcote, E. Jenny
Rasenack, Jens
Bzowej, Natalie
Naoumov, Nikolai V.
Brown, Nathaniel A.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A765 / A765
页数：1
相关论文
共 50 条
  • [21] Long-term Efficacy and Safety of Prolonged Telbivudine Treatment in Postpartum Patients with Chronic Hepatitis B
    Zhou, Yuejin
    Zheng, Jinli
    Xiao, Yang
    Pan, Huajiang
    HEPATOLOGY, 2012, 56 : 399A - 399A
  • [22] A phase III comparative trial of telbivudine vs lamivudine in Chinese patients with chronic hepatitis B: Two-year results
    Wang, Yuming
    Jia, Jidong
    Hou, Jinlin
    Yin, Youkuan
    Xu, Daozhen
    Tan, Deming
    Niu, Junqi
    Zhou, Xiaqiu
    Zhu, Limin
    Brown, Nathaniel A.
    GASTROENTEROLOGY, 2007, 132 (04) : A763 - A763
  • [23] EFFICACY AND SAFETY OF TELBIVUDINE IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS WITH HIGH BASELINE ALT LEVELS
    Lv Guocai
    Ma Wenjiang
    Ying Linjuan
    Jin Xi
    Zheng Lin
    Li Lan-juan
    Yang Yida
    HEPATOLOGY, 2010, 52 (04) : 552A - 553A
  • [24] A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study
    Tsai, M-C.
    Chen, C-H.
    Hung, C-H.
    Lee, C-M.
    Chiu, K-W.
    Wang, J-H.
    Lu, S-N.
    Tseng, P-L.
    Chang, K-C.
    Yen, Y-H.
    Hu, T-H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (02) : O90 - O100
  • [25] Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients
    Durante-Mangoni, E.
    Vitrone, M.
    Parrella, A.
    Andini, R.
    Iossa, D.
    Ragone, E.
    Falco, E.
    Maiello, C.
    Utili, R.
    Zampino, R.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 319 - 325
  • [26] A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B
    Lai, CL
    Leung, N
    Teo, EK
    Tong, M
    Wong, F
    Hann, HW
    Han, S
    Poynard, T
    Myers, M
    Chao, G
    Lloyd, D
    Brown, NA
    GASTROENTEROLOGY, 2005, 129 (02) : 528 - 536
  • [27] Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy
    Law, Siu-Tong
    Lee, Ming Kai
    Lee, Ann Shing
    Tung, Yuk
    Li, Kin Kong
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (05) : 325 - 333
  • [28] Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B
    Law, Siu-tong
    Lee, Ming Kai
    Li, Kin Kong
    Mok, Chun Keung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 193 - 198
  • [29] Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine
    Safadi, Rifaat
    Xie, Qing
    Chen, Yagang
    Yin, You-Kuan
    Wei, Lai
    Hwang, Seong Gyu
    Zuckerman, Eli
    Jia, Ji-Dong
    Lopez, Patricia
    LIVER INTERNATIONAL, 2011, 31 (05) : 667 - 675
  • [30] A randomized trial of telbivudine vs adefovir for HBeAg-positive chronic hepatitis B: Efficacy through week 76, predictors of response and effects of switching to telbivudine
    Bzowej, Natalie
    Marcellin, Patrick
    Chan, Henry Lik-Yuen
    Lai, Ching Lung
    Cho, Mong
    Heathcote, E. Jenny
    Moon, Young Myoung
    Chao, You Chen
    Myers, Robert P.
    Harb, George
    Brown, Nathaniel A.
    GASTROENTEROLOGY, 2007, 132 (04) : A764 - A764
12345